
About Exsure
Exsure is a Healthcare company based in Bhubaneswar (India) founded in 2021 by Swastika Paul and Abhishek Dutta. Developer of nano drug delivery platform for cancer treatment. Exsure has raised $346.88 thousand across 1 funding round from investors including Unicorn India Ventures. The company has 1 employees. Its chief executive, as recorded, is Abhishek Dutta. Its Indian entity Exsure Private Limited reported revenue of βΉ7.4 Lakh. Exsure offers products and services including EXOSURE, LEUCOSURE, and DENDROSURE. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
Exsure was founded in 2021 and is based in Bhubaneswar, India. Operations are centered in the biotechnology sector, where an exosome-based platform for chemotherapeutic drug delivery is being developed. Anti-cancer drugs are targeted precisely to tumor and relapse-causing cells through this technology, minimizing impact on healthy cells. The focus remains on advancing nano-scale solutions for oncology applications.
- Headquarters Bhubaneswar, India
- Employees 1
- Founders Swastika Paul, Abhishek Dutta
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website exsure.in
- Social LinkedIn X Facebook YouTube
- Legal Name Exsure Private Limited
- Date of Incorporation 18 Nov, 2021
- Jurisdiction Bhubaneswar, Odisha, India
- Annual Revenue₹7.4 Lakh
FY 2025 · -74% YoY
- Net Loss-₹14.2 Lakh
FY 2025 · -191% margin
- EBITDA-₹13.7 Lakh
FY 2025 · -185% margin
- Total Equity Funding$346.88K (USD)
in 1 rounds
- Latest Funding Round$346.88K (USD), Seed
Jan 2025
- Investors
- Employee Count1
Associated legal entities of Exsure
Exsure operates through Exsure Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Exsure Private Limited CIN U24239OR2021PTC038222 | Active | 18 Nov 2021 | Bhubaneswar, Odisha | ₹0.1 Cr | 2 | View details |
Products & Services of Exsure
Exsure offers a comprehensive portfolio of products and services, including EXOSURE, LEUCOSURE, and DENDROSURE.
Reagent for isolating exosomes from blood and cell-culture.
Lymphocyte separation reagent for blood samples.
Medium to convert monocytes into mature dendritic cells.
Apps and channels of Exsure
its YouTube channel EXSURE has 32 subscribers and 15 videos.
Videos from Exsure
The most watched videos on Exsure's YouTube channel, EXSURE (32 subscribers). Click a video to play it here.
More on EXSURE.
Funding Insights of Exsure
Exsure has successfully raised a total of $346.88K through 1 strategic funding round. The most recent funding activity was a Seed round of $346.88 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $346,878
- Total Rounds 1
- Last Round Seed β $346,878
- First Round $346,878
(Jan 2025)
- Investors Count 1
All 1 funding rounds of Exsure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $346,878 | Seed | β | Unicorn India Ventures | β |
1 investors in total: 1 institutional.
Investors in Exsure
Exsure has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Unicorn India Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering seed funding and support to startups in technology and innovation sectors. | 2014 | unicornivc.com | Mumbai, India |
Investor details for Exsure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Exsure Private Limited (Exsure)
Exsure Private Limited is the primary company behind Exsure. The board of Exsure Private Limited currently have 2 directors; the longest-serving is Abhishek Dutta, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhishek Dutta DIN 09405669 | Director | 18 Nov 2021 | 5 yrs | Exsure Private Limited |
| Swastika Paul DIN 09405670 | Director | 18 Nov 2021 | 5 yrs | Exsure Private Limited |
People of Exsure
2 people are tracked at Exsure (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Exsure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Exsure
Figures of Exsure Private Limited, the primary company behind Exsure, for FY 2025. Revenue was ₹7.4 Lakh (-74% year on year). Net loss was -₹14.2 Lakh (-191% margin). EBITDA was -₹13.7 Lakh (-185% margin).
- ₹7.4 LakhRevenue · FY 2025 · -74% YoY
- -₹14.2 LakhNet loss · -191% margin
- -₹13.7 LakhEBITDA · -185% margin
- ₹64,900Paid-up capital
Balance sheet, profit and loss, cash flow and ratios of Exsure Private Limited are on its company page.
Detailed financial statements for Exsure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Exsure
2 dated milestones of Exsure across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Exsure is founded.
- Funding First funding round of $347K.
Web traffic of Exsure
The website of Exsure (exsure.in) receives about 9.8K visits a month.
- Monthly visits9.8K
▲ 48.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Exsure (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exsure
Complete news archive for Exsure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exsure
Exsure was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Exsure is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
Abhishek Dutta is the CEO of Exsure, as recorded in our data. They have also founded this company.
Exsure is a funded company, having raised a total of $346.88K across 1 funding round to date. The company's 1st funding round was a Seed of $346.88K, raised on Jan 2025.
Exsure has 1 employees.
The primary company behind Exsure, Exsure Private Limited, reported revenue of βΉ7.4 Lakh for FY 2025, down 74% year on year.
Exsure was founded in 2021 and is based in Bhubaneswar, India. Operations are centered in the biotechnology sector, where an exosome-based platform for chemotherapeutic drug delivery is being developed. Anti-cancer drugs are targeted precisely to tumor and relapse-causing cells through this technology, minimizing impact on healthy cells. The focus remains on advancing nano-scale solutions for oncology applications.
Exsure offers EXOSURE, LEUCOSURE, and DENDROSURE.
Exsure has 1 investor. Key investors include Unicorn India Ventures.
Exsure operates through Exsure Private Limited.
The legal entities of Exsure currently have 2 directors, including Abhishek Dutta, Swastika Paul.
